PEAR
Pear Therapeutics, Inc. Class A Common Stock
PEAR
PEAR
Delisted
PEAR was delisted on the 18th of April, 2023.
85 hedge funds and large institutions have $257M invested in Pear Therapeutics, Inc. Class A Common Stock in 2021 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 13 increasing their positions, 9 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
85
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$9.94M | |
| 2 | +$8.62M | |
| 3 | +$7.51M | |
| 4 |
OPU
Omni Partners US
Irvine,
California
|
+$6.61M |
| 5 |
SRF
Silver Rock Financial
Los Angeles,
California
|
+$6.29M |
Top Sellers
| 1 | -$2.96M | |
| 2 | -$2.96M | |
| 3 | -$1.98M | |
| 4 |
CL
CSS LLC
Chicago,
Illinois
|
-$1.56M |
| 5 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$1.48M |